FACULTY
Jay H. Shubrook Jr, DO, FACOFP, FAAFP, BC-ADM
Professor, Primary Care Department
Director, Clinical Research and Diabetes Services
College of Osteopathic Medicine
Touro University California
Vallejo, CA
Richard E. Pratley, MD
Samuel E. Crockett Chair in Diabetes Research
Medical Director-Advent Health Diabetes Institute
Senior Investigator and Diabetes Program Lead, Advent Health
Translational Research Institute
Adjunct Professor of Medicine, Johns Hopkins University School of Medicine
Orlando, FL
Also featuring
Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
Vice-Chair & Allen I. White Distinguished Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences
Washington State University
Spokane, WA
Phyllisa Deroze, PhD
Director of Research at dQ&A
Founder of Black Diabetic Info
Pompano Beach, Florida
PROGRAM OVERVIEW
This activity will address the challenges faced by clinicians in managing older patients with T2DM. Participants will be equipped with an enhanced ability to apply current guideline recommendations and clinical data to management plans, personalize diabetes treatment for older adults in long-term care facilities and in the community, and gain greater knowledge of the rationale for using fixed ratio combinations of basal insulin and GLP-1 receptor agonists in older adults with T2DM.
TARGET AUDIENCE
This educational activity is intended for geriatricians, endocrinologists, primary care clinicians (including physicians, nurse practitioners, physician assistants, nurses and consultant pharmacists), and managed care professionals caring for older adults with T2DM overall and in long-term care settings.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Evaluate current guidelines recommendations and clinical data pertinent to the management of T2DM in older adults.
- Create personalized treatment plans for older patients with T2DM in long-term care facilities and in the community.
- Explain the clinical rationale for using fixed ratio combinations of GLP-1 receptor agonists and basal insulin in older adults in community and LTC settings.
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group will designate this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
This program would be beneficial for nurses involved in the care of patients with diabetes.
CNE credits: 1.0 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
COMMISION ON DIETETIC REGISTRATION
This program has received prior approval with the Commission on Dietetic Registration for dietitians and RDs.
It is the responsibility of the dietitians to log the MLG activity into their CDR activity log in order to receive credit. Dietitians should also keep their certificate of completion in the event they are randomly audited by CDR.
Dietitians may submit feedback on the activity to [email protected]
AAFP CREDIT INFORMATION
The AAFP has reviewed Reducing Treatment Complexity in Older Adults with T2DM: The Role of Fixed-Ratio GLP-1 Receptor Agonist/Insulin Combinations and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 10/28/2022 to 10/28/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
| Faculty Member | Disclosures |
| Jay H. Shubrook Jr, DO | Dr. Shubrook is a consultant for Bayer and Novo Nordisk. |
| Richard E. Pratley, MD | Dr. Pratley discloses as of June 11, 2011 all services rendered by Richard E. Pratley, MD are paid directly to AdventHealth, a non-profit organization. Dr. Pratley does not receive any direct or indirect compensation for these services. |
| Joshua J. Neumiller, PharmD | Dr. Neumiller is a consultant for Sanofi and Bayer. He is also a member of a speakers’ bureau for Dexcom. |
| Phyllisa Deroze, PhD | Dr. Deroze has nothing to disclose. |
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
- Cindy Lampner, MSLIS, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Melissa Johnson, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Amanda Jenkins, Program Manager for Med Learning Group, has nothing to disclose.
- Natalie Smith, Program Coordinator for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit, participants must:
- Read the CME/CNE information and faculty disclosures
- Participate in the enduring activity
- Complete posttest and evaluation form online
Participants will receive their certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://medlearninggroup.com/privacy-policy/.
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASE DATE: October 26, 2022
EXPIRATION DATE: October 26, 2023
Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
